Mevox
MEVOX is a company that combines in-house expertise with world-class partnerships in antigen design and vaccine development. They leverage cutting-edge vaccine innovation and translational expertise to bring established vaccines into the 21st century, addressing significant unmet needs. Their mission is to achieve global health impact through protection by design, applying atomic level antigen characterization, structure-based design, and engineering to optimize immunogenicity, safety, producibility, and access. They partner with world-class expertise to minimize barriers to access and aim to unleash human potential by removing the burden of infectious disease.
Industries
Nr. of Employees
small (1-50)
Services
Antigen and vaccine design
Structure-guided antigen design and protein engineering services to produce conformationally precise vaccine antigens.
Translational vaccine development partnerships
Collaborative translational programs that move antigen candidates from discovery toward clinical evaluation through external partnerships.
CMC, formulation and stabilization development
Formulation development, stabilization and CMC support to enable manufacturable and stable vaccine products.
Bioinformatics support for vaccine programs
Bioinformatics analyses to support antigen selection, sequence design and immunogen prioritization.
Regulatory and clinical advisory
Regulatory strategy and clinical development advisory services for vaccine programs, informed by advisors with licensing and clinical experience.
Antigen and vaccine design
Structure-guided antigen design and protein engineering services to produce conformationally precise vaccine antigens.
Translational vaccine development partnerships
Collaborative translational programs that move antigen candidates from discovery toward clinical evaluation through external partnerships.
CMC, formulation and stabilization development
Formulation development, stabilization and CMC support to enable manufacturable and stable vaccine products.
Bioinformatics support for vaccine programs
Bioinformatics analyses to support antigen selection, sequence design and immunogen prioritization.
Regulatory and clinical advisory
Regulatory strategy and clinical development advisory services for vaccine programs, informed by advisors with licensing and clinical experience.
Expertise Areas
- Structure-based vaccine design
- Recombinant protein vaccine development
- Structural biology and antigen characterization
- Vaccine formulation and stabilization
Key Technologies
- Structure-based antigen design
- Protein engineering
- Atomic-level structural characterization
- Bioinformatics and sequence analysis